- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-190X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy ; volume:31 ; number:4 ; day:1 ; month:7 ; year:2017 ; pages:317-334 ; date:8.2017
BioDrugs ; 31, Heft 4 (1.7.2017), 317-334, 8.2017
- Keyword
-
Nichtmedikamentöse Therapie
- Creator
-
Naso, Michael F.
- Contributor
-
Tomkowicz, Brian
Perry, William L.
Strohl, William R.
SpringerLink (Online service)
- DOI
-
10.1007/s40259-017-0234-5
- URN
-
urn:nbn:de:1111-201710254211
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Naso, Michael F.
- Tomkowicz, Brian
- Perry, William L.
- Strohl, William R.
- SpringerLink (Online service)
Other Objects (12)
Molecular design for recombinant adeno-associated virus (rAAV) vector production
Adeno-Associated Virus (AAV) vectors in gene therapy
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Adeno-associated virus: from defective virus to effective vector
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Small but increasingly mighty: new insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Small but increasingly mighty: New insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
Induction of hepatitis E virus anti-ORF3 antibodies from systemic administration of a muscle-specific adeno-associated virus (AAV) vector
Influence of the SUMOylation pathway on adeno-associated virus vector transduction
Molecular design for recombinant adeno-associated virus (rAAV) vector production
Adeno-Associated Virus (AAV) vectors in gene therapy
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Adeno-associated virus: from defective virus to effective vector
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Small but increasingly mighty: new insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Small but increasingly mighty: New insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
Induction of hepatitis E virus anti-ORF3 antibodies from systemic administration of a muscle-specific adeno-associated virus (AAV) vector
Influence of the SUMOylation pathway on adeno-associated virus vector transduction
Molecular design for recombinant adeno-associated virus (rAAV) vector production
Adeno-Associated Virus (AAV) vectors in gene therapy
Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
Adeno-associated virus: from defective virus to effective vector
Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Small but increasingly mighty: new insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Small but increasingly mighty: New insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization
Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
Induction of hepatitis E virus anti-ORF3 antibodies from systemic administration of a muscle-specific adeno-associated virus (AAV) vector